<生产厂家价格>

5-溴-1-茚酮

5-溴-1-茚酮用途

5-溴-2,3-二氢-1H-茚-1-酮是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

5-溴-1-茚酮名称

[ CAS 号 ]:
34598-49-7

[ 中文名 ]:
5-溴茚酮

[ 英文名 ]:
5-Bromoindanone

[中文别名 ]:

[英文别名 ]:

5-Bromoindan-1-one
5-Bromo-1-indanone
1H-Inden-1-one, 5-bromo-2,3-dihydro-
1-Indanone, 5-bromo-
1H-Inden-1-one,5-bromo-2,3-dihydro
1-Indanone,5-bromo
5-bromoindane-1-one
5-Bromindan-1-on
5-bromo-2,3-dihydro-1H-indene-1-one
MFCD00082718

5-溴-1-茚酮生物活性

[ 描述 ]:

5-溴-2,3-二氢-1H-茚-1-酮是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

5-溴-1-茚酮物理化学性质

[ 密度 ]:
1.6±0.1 g/cm3

[ 沸点 ]:
303.7±31.0 °C at 760 mmHg

[ 熔点 ]:
126-129 °C(lit.)

[ 分子式 ]:
C₉H₇BrO

[ 分子量 ]:
211.06

[ 闪点 ]:
120.2±12.2 °C

[ 精确质量 ]:
209.968018

[ PSA ]:
17.07000

[ LogP ]:
2.86

[ 外观性状 ]:
淡黄色至灰白色粉末

[ 蒸汽压 ]:
0.0±0.6 mmHg at 25°C

[ 折射率 ]:
1.623

[ 储存条件 ]:
-20°C

5-溴-1-茚酮MSDS

5-溴-1-茚酮安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H302-H312-H315-H319-H332-H335

[ 警示性声明 ]:
P261-P280-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xn:Harmful

[ 风险声明 (欧洲) ]:
R22;R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36-S36/37/39

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2914700090

5-溴-1-茚酮合成路线

5-溴-1-茚酮上下游产品

5-溴-1-茚酮上游产品

5-溴-1-茚酮下游产品

5-溴-1-茚酮海关

[ 海关编码 ]: 2914700090

[ 中文概述 ]:
2914700090 其他酮及醌的卤化、磺化衍生物（包括硝化和亚硝化衍生物）. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:5.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 丙酮报明包装

[ Summary ]:
HS: 2914700090 halogenated, sulphonated, nitrated or nitrosated derivatives of ketones and quinones, whether or not with other oxygen function Tax rebate rate:9.0% Supervision conditions:none VAT:17.0% MFN tariff:5.5% General tariff:30.0%

5-溴-1-茚酮文献

Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.

J. Med. Chem. 54 , 4219-4233, (2011)

Mining of an in-house collection of angiotensin II type 1 receptor antagonists to identify compounds with activity at the peroxisome proliferator-activated receptor-γ (PPARγ) revealed a new series of ...

Novel imidazolyl and triazolyl substituted biphenyl compounds: synthesis and evaluation as nonsteroidal inhibitors of human 17alpha-hydroxylase-C17, 20-lyase (P450 17).

Bioorg. Med. Chem. 8(6) , 1245-52, (2000)

The synthesis of a new series of P450 17 inhibitors is described. The imidazol-1-yl compounds 5 showed strong inhibition of P450 17 rat and especially human enzyme, the most active compounds being 5ax...

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.

Bioorg. Med. Chem. Lett. 16(2) , 378-381, (2006)

A novel triarylimidazole derivative, SB-590885 (33), bearing a 2,3-dihydro-1H-inden-1-one oxime substituent has been identified as a potent and extremely selective inhibitor of B-Raf kinase.

更多文献